Your journey to better metabolic health is unique, and it's essential to find the approach that works best for you, with the guidance of your healthcare team.
A deficiency of growth hormone can also raise LDL cholesterol levels
Novo Nordisk followed in 2025 with NovoCare Pharmacy, focused on stabilizing access to its high-demand GLP-1 therapies Wegovy and Ozempic, providing transparent cash-pay rails by publishing flat prices for GLP-1 therapies
Dedicated medical advice is recommended for addressing these concerns and finding an effective solution
However, being significantly overweight or obese can increase the risk of conditions such as heart disease, diabetes, and joint problems at any age
Despite promising indications, further research is needed to understand its long term effects.